XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 49,985,000 $ 73,981,000
Marketable securities 110,525,000 22,518,000
Accounts receivable, net 1,775,000 0
Inventories 1,439,000 0
Research and development tax credit receivable 974,000 2,248,000
Prepaid expenses and other current assets 6,532,000 2,096,000
Total current assets 171,230,000 100,843,000
Property and equipment, net 715,000 839,000
Operating lease right-of-use assets 1,235,000 1,713,000
Goodwill 16,836,000 16,836,000
Research and development tax credit receivable 420,000 1,232,000
Other non-current assets 10,540,000 11,322,000
Total assets 200,976,000 132,785,000
Current liabilities:    
Current portion of long-term debt 20,851,000 37,668,000
Current portion of operating lease liability 783,000 960,000
Accounts payable 11,786,000 7,890,000
Accrued expenses 17,582,000 7,334,000
Other current liabilities 500,000 1,941,000
Total current liabilities 51,502,000 55,793,000
Long-term debt 0 91,614,000
Long-term operating lease liability 490,000 780,000
Other non-current liabilities 5,792,000 5,743,000
Total liabilities 57,784,000 153,930,000
Shareholders’ equity (deficit):    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 5,194 issued and outstanding at June 30, 2023 and 488 issued and outstanding at December 31, 2022 52,000 5,000
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 89,321 issued and outstanding at June 30, 2023 and 62,878 issued and outstanding at December 31, 2022 893,000 628,000
Additional paid-in capital 848,626,000 589,783,000
Accumulated deficit (680,436,000) (585,220,000)
Accumulated other comprehensive loss (25,943,000) (26,341,000)
Total shareholders’ equity (deficit) 143,192,000 (21,145,000)
Total liabilities and shareholders’ equity (deficit) $ 200,976,000 $ 132,785,000